{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Seattle Genetics", "item": "https://www.patentleaderboard.com/2021/company/seattle-genetics"}, {"@type": "ListItem", "position": 4, "name": "Eric Sievers", "item": "https://www.patentleaderboard.com/2021/inventor/fl:er_ln:sievers-1"}]}

Home › 2021 › Seattle Genetics › Eric Sievers

Eric Sievers — 3 Patents in 2021

SESeagen: 3 patents #2 of 44Top 5%

Bothell, WA: #43 of 455 inventorsTop 10%

Washington: #1,376 of 13,672 inventorsTop 15%

Overall (2021): #84,005 of 548,734Top 20%

3 Patents 2021

Issued Patents 2021

Showing 1–3 of 3 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11077164	Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates	Dana Kennedy	2021-08-03	$138,536,000
10940178	Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates	Dana Kennedy	2021-03-09	$291,417,000
10912813	Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates	Dana Kennedy	2021-02-09	$172,047,000

Eric Sievers — 3 Patents in 2021

Issued Patents 2021

Patent Widget